Actuate Therapeutics, Inc.
ACTU
$7.67
-$0.01-0.13%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.68M | -25.31M | -27.29M | -28.45M | -28.82M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.14M | 4.79M | 4.34M | 3.32M | 2.24M |
| Change in Net Operating Assets | -3.17M | -694.60K | 1.10M | 2.54M | 7.50M |
| Cash from Operations | -22.71M | -21.21M | -21.84M | -22.58M | -19.07M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 200.00K | 1.20M | 5.70M | 5.70M | 5.50M |
| Total Debt Repaid | -200.00K | -200.00K | -200.00K | -200.00K | -- |
| Issuance of Common Stock | 31.16M | 23.96M | 23.96M | 23.96M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.31M | -1.92M | -1.93M | -1.82M | -185.80K |
| Cash from Financing | 28.85M | 23.03M | 27.53M | 27.64M | 5.31M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.14M | 1.82M | 5.68M | 5.05M | -13.76M |